Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with moyamaya disease

Stroke

Volumn 28, Issue 9, 1997, Pages 1733-1738

  Yamamoto, Mari ^c   Aoyagi, Masaru ^c   Tajima, Shingo ^a   Wachi, Hiroshi ^a   Fukai, Naomi ^c   Matsushima, Yoshiharu ^c   Yamamoto, Kiyotaka ^b  

^a National Defense Medical School   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c NONE

Author keywords

Extracellular matrix; Moyamoya disease; Muscle, smooth; Transforming growth factor

Indexed keywords

ELASTIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ARTERY MUSCLE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CHILD; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; MOYAMOYA DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; STROKE; SUPERFICIAL TEMPORAL ARTERY;

EID: 0030775587     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.9.1733     Document Type: Article

References (42)

1. Kudo T. Spontaneous occlusion of the circle of Willis: a disease apparently confined to Japanese. Neurology. 1968;20:485-496.
2. Nishimoto A, Takeuchi S. Abnormal cerebrovascular network related to the internal carotid arteries. J Neurosurg. 1968;29: 255-260.
3. Suzuki J, Kodama N. Moyamoya disease: a review. Stroke. 1983;14: 104-109.
4. Haltia M, Iivanainen M, Majuri H, Puranen M. Spontaneous occlusion of the circle of Willis (moyamoya syndrome). Clin Neuropathol. 1982;1:11-22.
5. Hosoda Y. Pathology of so-called 'spontaneous occlusion of the circle of Willis.' Pathol Annu. 1984;19:221-244.
6. Takebayashi S, Matsuo K. Kaneko M. Ultrastructural studies of cerebral arteries and collateral vessels in moyamoya disease. Stroke. 1984;15:728-732.
7. Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke. 1983;14:50-58.
8. Ellison PH, Largent JA, Popp AJ. Moya-moya disease associated with renal artery stenosis. Arch Neurol. 1981;38:467.
9. Halley SE, White WB, Ramsby GR, Voytovich AE. Renovascular hypertension in moyamoya syndrome: therapeutic response to percutaneous transluminal angioplasty. Am J Hypertens. 1988;1: 348-352.
10. Ikeda E. Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke. 1991;22:1358-1362.
11. Lee MLK, Cheung EMT. Moyamoya disease as a cause of subarachnoid hemorrhage in Chinese. Brain. 1973;96:623-628.
12. livanainen M, Vuolio M, Halonen V. Occlusive disease of intracranial main arteries with collateral networks (moyamoya disease) in adults. Acta Neurol Scand. 1973;49:307-322.
13. Kitahara T, Ariga N, Yamaura A, Makino H, Maki Y. Familial occurrence of moyamoya disease: report of three Japanese families. J Neuro Neurosurg Psychiatry: 1979;42:208-214.
14. Houkin K, Tanaka N, Takahashi A, Kamiyama H, Abe H, Kajii N. Familial occurrence of moyamoya disease: magnetic resonance angiography as a screening test for high-risk subjects. Childs Nerv Syst. 1994;10:421-425.
15. Aoyagi M, Fukai N, Sakamoto H, Shinkai T, Matsushima Y, Yamamoto M, Yamamoto K. Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease. J Cell Physiol. 1991;147:191-198.
16. 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease. J Cell Physiol. 1993;154:281-288.
17. Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett. 1993;160:214-216.
18. Yoshimoto T, Houkin K, Takahashi A, Abe H. Angiogenic factors in moyamoya disease. Stroke. 1996;27:2160-2165.
19. Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K. Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke. 1996;27:1750-1754.
20. Matsushima Y, Fukai N, Tanaka K, Tsuruoka S, Inaba Y, Aoyagi M, Ohno K. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol. 1981;15:313-320.
21. Hayashi A, Suzuki T, Wachi H, Tajima S, Nishikawa T, Murad S, Pinnell SR. Minoxidil stimulates elastin expression in aortic smooth muscle cells. Arch Biochem Biophys. 1994;315:137-141.
22. Tokimutsu I, Kato H, Wachi H, Tajima S. Elastin synthesis is inhibited by angiotensin II but not by platelet-derived growth factor in arterial smooth muscle cells. Biochim Biophys Acta. 1994;1207: 68-73.
23. Yamamoto K, Aoyagi M, Yamamoto M. Changes in elastin-binding proteins during the phenotypic transition of rabbit arterial smooth muscle cells in primary culture. Exp Cell Res. 1995;218:339-345.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
25. Yamamoto M, Nakamura H, Yamato M, Aoyagi M, Yamamoto K. Retardation of phenotypic transition of rabbit arterial smooth muscle cells in three-dimensional primary culture. Exp Cell Res. 1996;225:12-21.
26. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor beta-1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
27. Liu J-M, Davidson JM. The elastogenic effect of recombinant transforming growth factor-beta on porcine aortic smooth muscle cells. Biochem Biophys Res Commun. 1988;154:895-901.
28. McGowan SE. Influences of endogenous and exogenous TGF-β on elastin in rat lung fibroblasts and aortic smooth muscle cells. Am J Physiol. 1992;263:L257-L263.
29. Davidson JM, Zoia O, Liu J-M. Modulation of transforming growth factor-beta 1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor, transforming growth factor-α, and insulin-like growth factor-I. J Cell Physiol. 1993;155: 149-156.
30. Yamashita M, Oka K, Tanaka K. Cervico-cephalic arterial thrombi and thromboemboli in moyamoya disease: possible correlation with progressive intimai thickening 'in the intracranial major arteries Stroke. 1984;15:264-270.
31. Masuda J, Ogata J, Yutani C. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke. 1993;24:1960-1967.
32. Yue TL, Wang XK, Olson B, Feuerstein G. Interleukin-1 beta (IL-1 beta) induces transforming growth factor-beta, (TCP-beta 1) production by rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1994;204:1186-1192.
33. Kähäri V-M, Olsen DR, Rhudy RW, Carrillo P, Chen YQ, Uitto J. Transforming growth factor-β up-regulates elastin gene expression in human skin fibroblasts: evidence for post-transcriptional modulation. Lab Invest. 1992;66:580-588.
34. Snow AD, Bolender RP, Wight TN, Clowes AW. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol. 1990;137: 313-330.
35. Nikkari ST, Järveläinen HT, Wight TN, Ferguson M, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 1994;144:1348-1356.
36. Strauss BH, Cisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994; 75:650-658.
37. Curran ME, Atkinson DL, Ewart AK, Morris CA, Leppert MF, Keating MT. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell. 1993;73:159-168.
38. Ewart AK, Morris CA, Ensing GJ, Loker J, Moore C, Leppert M, Keating M. A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. Proc Natl Acad Sci USA 1993;90: 3226-3230.
39. Kawai M, Nishikawa T, Tanaka M, Ando A, Kasajima T, Higa T, Tanikawa T, Kagawa M, Momma K. An autopsied case of Williams syndrome complicated by moyamoya disease. Acta Paediatr Jpn. 1993;35:63-67.
40. Marigo V, Volpin D, Bressan GM. Regulation of the human elastin promoter in chick embryo cells. Tissue-specific effect of TGF-β. Biochim Biophys Acta. 1993;1172:31-36.
41. Marigo V, Volpin D, Vitale G, Bressan GM. Identification of a TGF-β responsive element in the human elastin promoter. Biochem Biophys Res Commun. 1994;199:1049-1056.
42. Kähäri V-M, Chen YQ, Bashir MM, Rosenbloom J, Uitto J. Tumor necrosis factor-α down-regulates human elastin gene expression-evidence for the role of AP-1 in the suppression of promoter activity. J Biol Chem. 1992;267:26134-26141.